LT3062824T - Telomerazė, koduojanti dnr vakciną - Google Patents

Telomerazė, koduojanti dnr vakciną

Info

Publication number
LT3062824T
LT3062824T LTEP14790592.1T LT14790592T LT3062824T LT 3062824 T LT3062824 T LT 3062824T LT 14790592 T LT14790592 T LT 14790592T LT 3062824 T LT3062824 T LT 3062824T
Authority
LT
Lithuania
Prior art keywords
dna vaccine
telomerase
coding
telomerase coding
vaccine
Prior art date
Application number
LTEP14790592.1T
Other languages
English (en)
Inventor
Pierre Langlade Demoyen
Simon Wain-Hobson
Thierry Huet
Christelle LIARD
Elodie PLIQUET
Original Assignee
Invectys
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invectys filed Critical Invectys
Publication of LT3062824T publication Critical patent/LT3062824T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • A61K39/001154Enzymes
    • A61K39/001157Telomerase or TERT [telomerase reverse transcriptase]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/10Cellular immunotherapy characterised by the cell type used
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1276RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/35Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07049RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
LTEP14790592.1T 2013-10-28 2014-10-28 Telomerazė, koduojanti dnr vakciną LT3062824T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13190547 2013-10-28
PCT/EP2014/073164 WO2015063117A1 (en) 2013-10-28 2014-10-28 A telomerase encoding dna vaccine

Publications (1)

Publication Number Publication Date
LT3062824T true LT3062824T (lt) 2020-05-25

Family

ID=49515221

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP14790592.1T LT3062824T (lt) 2013-10-28 2014-10-28 Telomerazė, koduojanti dnr vakciną

Country Status (25)

Country Link
US (2) US10183065B2 (lt)
EP (2) EP3062824B1 (lt)
JP (1) JP6545162B2 (lt)
KR (1) KR102252756B1 (lt)
CN (1) CN106061509B (lt)
AU (1) AU2014343813B2 (lt)
BR (1) BR112016009002B1 (lt)
CA (1) CA2927702C (lt)
CY (1) CY1122839T1 (lt)
DK (1) DK3062824T3 (lt)
EA (1) EA034928B1 (lt)
ES (1) ES2771862T3 (lt)
HR (1) HRP20200211T1 (lt)
HU (1) HUE047898T2 (lt)
IL (1) IL245186B (lt)
LT (1) LT3062824T (lt)
MX (1) MX372778B (lt)
NZ (1) NZ719098A (lt)
PL (1) PL3062824T3 (lt)
PT (1) PT3062824T (lt)
RS (1) RS60232B1 (lt)
SG (1) SG11201603118TA (lt)
SI (1) SI3062824T1 (lt)
WO (1) WO2015063117A1 (lt)
ZA (1) ZA201603452B (lt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10183065B2 (en) 2013-10-28 2019-01-22 Invectys Telomerase encoding DNA vaccine
DK3359183T3 (da) * 2015-10-06 2020-08-03 Invectys Polyepitop-konstrukter til anvendelse i immunoterapy
US11351246B2 (en) 2017-05-09 2022-06-07 Invectys SAS Recombinant measles vaccine expressing hTERT
WO2021014428A1 (en) * 2019-07-25 2021-01-28 Novartis Ag Regulatable expression systems
EP4103717A4 (en) * 2020-02-12 2024-02-28 The Children's Hospital of Philadelphia COMPOSITIONS AND METHODS FOR INDUCIBLE ALTERNATIVE SPLICING REGULATION OF GENE EXPRESSION
WO2021263081A2 (en) * 2020-06-26 2021-12-30 National Breast Cancer Coalition Breast cancer vaccine
AU2021298886A1 (en) * 2020-07-03 2023-02-09 Statens Serum Institut A dna plasmid SARS-Coronavirus-2/covid-19 vaccine
CN112063601B (zh) * 2020-09-22 2023-06-02 浙江愈方生物科技有限公司 一种灭活性端粒酶、具有其的腺病毒和人造mRNA及应用
US20220370598A1 (en) * 2021-05-05 2022-11-24 Inovio Pharmaceuticals, Inc. Vaccines Against Coronavirus and Methods of Use
WO2024126758A2 (en) * 2022-12-14 2024-06-20 Ultimovacs Ab A nucleic acid molecule and a chimeric polypeptide

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04504416A (ja) 1989-02-17 1992-08-06 コセルコ・ミモトープス・ピィ・ティ・ワイ.エル・ティ・ディ. ペプチドの使用方法と合成方法
US5840839A (en) 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
EP0932686A2 (en) 1996-10-01 1999-08-04 Geron Corporation Telomerase reverse transcriptase
AU2002363231A1 (en) 2001-10-29 2003-05-12 Baylor College Of Medicine Human telomerase reverse transcriptase as a class-ii restricted tumor-associated antigen
EP1572090A4 (en) 2002-06-27 2006-11-15 Geron Corp CANCER VACCINE WITH CROSS-SPEED EPITOPES OF THE TELOMERASE REVERSE TRANSCRIPTASE
EP1748067A1 (en) 2005-07-29 2007-01-31 Institut Pasteur Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
US20090162405A1 (en) 2006-12-14 2009-06-25 Yong Qian Proteinase-engineered cancer vaccine induces immune responses to prevent cancer and to systemically kill cancer cells
EP2076531B1 (en) * 2006-10-12 2011-11-23 Istituto di Ricerche di Biologia Molecolare P. Angeletti S.R.L. Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof
JP5630769B2 (ja) * 2008-04-11 2014-11-26 井戸川 雅史 アポトーシス誘導剤
WO2010037395A2 (en) 2008-10-01 2010-04-08 Dako Denmark A/S Mhc multimers in cancer vaccines and immune monitoring
JP2012039877A (ja) 2009-04-10 2012-03-01 Fukuoka Univ ユビキチン融合遺伝子およびそれを用いたdnaワクチン
RU2539991C2 (ru) 2009-12-16 2015-01-27 Кронтек Фарма Аб Впрыскивающие игла и устройство
EP2978445B1 (en) 2013-03-28 2018-07-04 Invectys A cancer vaccine for cats
CA2908143C (en) 2013-03-28 2021-08-31 Invectys A cancer vaccine for dogs
US10183065B2 (en) 2013-10-28 2019-01-22 Invectys Telomerase encoding DNA vaccine
CN111909278B (zh) * 2014-01-27 2024-04-09 分子模板公司 Mhc i类表位递送多肽

Also Published As

Publication number Publication date
CA2927702A1 (en) 2015-05-07
KR102252756B1 (ko) 2021-05-17
SG11201603118TA (en) 2016-05-30
JP6545162B2 (ja) 2019-07-17
US10183065B2 (en) 2019-01-22
SI3062824T1 (sl) 2020-04-30
RS60232B1 (sr) 2020-06-30
CY1122839T1 (el) 2021-10-29
EA034928B1 (ru) 2020-04-08
IL245186A0 (en) 2016-06-30
HK1225986A1 (en) 2017-09-22
AU2014343813B2 (en) 2020-02-27
WO2015063117A1 (en) 2015-05-07
EP3666290A1 (en) 2020-06-17
ES2771862T3 (es) 2020-07-07
AU2014343813A1 (en) 2016-05-19
JP2017502649A (ja) 2017-01-26
PT3062824T (pt) 2020-02-21
EP3062824B1 (en) 2019-11-27
EA201690884A1 (ru) 2016-11-30
DK3062824T3 (da) 2020-02-17
ZA201603452B (en) 2020-08-26
US20190000946A1 (en) 2019-01-03
US20160263204A1 (en) 2016-09-15
KR20160111362A (ko) 2016-09-26
CA2927702C (en) 2022-06-07
BR112016009002B1 (pt) 2023-05-02
PL3062824T3 (pl) 2020-06-15
HUE047898T2 (hu) 2020-05-28
MX2016005389A (es) 2016-08-03
EP3062824A1 (en) 2016-09-07
IL245186B (en) 2021-02-28
MX372778B (es) 2020-06-29
CN106061509B (zh) 2022-04-08
NZ719098A (en) 2022-08-26
HRP20200211T1 (hr) 2020-05-15
CN106061509A (zh) 2016-10-26
BR112016009002A2 (pt) 2017-10-03
US12064474B2 (en) 2024-08-20

Similar Documents

Publication Publication Date Title
FR3006466B3 (fr) .
BR302014001376S1 (pt) Configuração aplicada em bolsa.
LT3074534T (lt) Būdai, skirti polinukleotido sekoskaitai
LT3062824T (lt) Telomerazė, koduojanti dnr vakciną
HRP20181376T1 (hr) Poboljšana cjepiva protiv poksvirusa
DK2975030T3 (da) Dihydropyridazin-3,5-dion-derivat
EP2995028A4 (en) RECOVERY OF N-UPLETS
FR3001302B1 (fr) .
EP2796910C0 (de) Endkappe
CL2016001315A1 (es) Separador.
DK2958935T3 (da) Vaccine
EP2923944A4 (en) ornithopter
FR3001303B1 (fr) .
DE112014002244A5 (de) Infusionslösung
GB201315714D0 (en) DNA Construct
BR302013000239S1 (pt) Configuração aplicada em tamanco.
GB201306171D0 (en) Cawesway-coclaine, mod enhancers
UA27551S (uk) Пуф
GB201312935D0 (en) T,b,s
TH148359B (th) ไพรโรลิดีน-2-คาร์บอกซาไมด์ที่ถูกแทนที่
BR302013000594S1 (pt) Configuração aplicada em alça.
ES1086579Y (es) Vaso multiusos
BR302013006684S1 (pt) Configuração aplicada em garrafa.
BR302013000627S1 (pt) Configuração aplicada em grelha.
ES1134036Y (es) Sacacorchos